Literature DB >> 9191472

Effect of IL-1 beta on responses of cultured human airway smooth muscle cells to bronchodilator agonists.

S A Shore1, J Laporte, I P Hall, E Hardy, R A Panettieri.   

Abstract

Decreased beta-adrenergic responsiveness is a characteristic feature of asthma. In order to determine whether cytokines released in the asthmatic airway contribute to this phenomenon, we measured changes in stiffness of cultured human airway smooth muscle (HASM) cells induced by isoproterenol (ISO) in control HASM cells and HASM cells pretreated with IL-1 beta (20 ng/ml for approximately 42 h). Stiffness was measured by magnetic twisting cytometry. HASM cells were obtained from normal tracheal tissue obtained at lung transplant, and studied in passages 4-7. In control cells, ISO caused a dose-related decrease in cell stiffness. IL-1 beta had no effect on baseline cell stiffness. However, IL-1 beta caused a rightward shift in the concentration-response curve to ISO and decreased the maximal effectiveness of this agonist. Decreased responses to ISO were also obtained with 2 ng/ml IL-1 beta, or when cells were pretreated with IL-1 beta (20 ng/ml) for 22 h. This effect of IL-1 beta was not altered by pretreatment of the cells with pertussis toxin (100 ng/ml throughout the IL-1 beta exposure period). IL-1 beta also significantly attenuated the ability of prostaglandin E2 (PGE2) to decrease cell stiffness. In contrast, IL-1 beta had no effect on cell stiffness responses to dibutryl cAMP, a cell permeant analog of cAMP suggesting that the cytokine does not influence either the ability of cAMP to activate kinases, or the targets of these kinases which ultimately mediate cell relaxation. IL-1 beta (20 ng/ml for 40 h) caused a small (30%) but significant (P < 0.02) increase in basal cAMP, but also resulted in a 2-3-fold decrease in the changes in cAMP formation induced by either ISO or PGE2. In contrast, IL-1 beta had no effect on cAMP formation in response to forskolin, suggesting that IL-1 beta does not mediate its effects via changes in the expression or activity of adenylyl cyclase. Pretreatment with IL-1 beta had no significant effect on beta 2 adrenoceptor number assessed by [125I]-CYP binding in these cells, nor was there any significant effect of IL-1 beta on Gsa expression assessed by Western blot. In summary, our results indicate that IL-1 beta causes a concentration- and time-dependent decrease in responses of HASM cells to ISO and are consistent with the hypothesis that the effects of IL-1 beta are mediated by uncoupling of beta-receptors from Gs-induced activation of adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191472     DOI: 10.1165/ajrcmb.16.6.9191472

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  25 in total

Review 1.  Does airway smooth muscle express an inflammatory phenotype in asthma?

Authors:  Gautam Damera; Reynold A Panettieri
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 2.  [Endoscopic asthma therapy. Sense and nonsense].

Authors:  F J F Herth
Journal:  Internist (Berl)       Date:  2008-11       Impact factor: 0.743

Review 3.  Cytokines induce airway smooth muscle cell hyperresponsiveness to contractile agonists.

Authors:  Y Amrani; R A Panettieri
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

4.  beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells.

Authors:  M P Hallsworth; C H Twort; T H Lee; S J Hirst
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

5.  Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways.

Authors:  Kent Miner; Katja Labitzke; Benxian Liu; Paul Wang; Kathryn Henckels; Kevin Gaida; Robin Elliott; Jian Jeffrey Chen; Longbin Liu; Anh Leith; Esther Trueblood; Kelly Hensley; Xing-Zhong Xia; Oliver Homann; Brian Bennett; Mike Fiorino; John Whoriskey; Gang Yu; Sabine Escobar; Min Wong; Teresa L Born; Alison Budelsky; Mike Comeau; Dirk Smith; Jonathan Phillips; James A Johnston; Joseph G McGivern; Kerstin Weikl; David Powers; Karl Kunzelmann; Deanna Mohn; Andreas Hochheimer; John K Sullivan
Journal:  Front Pharmacol       Date:  2019-02-14       Impact factor: 5.810

Review 6.  Drug disposition in pathophysiological conditions.

Authors:  Adarsh Gandhi; Bhagavatula Moorthy; Romi Ghose
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

7.  Interleukin-1alpha and tumour necrosis factor-alpha modulate airway smooth muscle DNA synthesis by induction of cyclo-oxygenase-2: inhibition by dexamethasone and fluticasone propionate.

Authors:  R Vlahos; A G Stewart
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

8.  Despite increased plasma concentration, inflammation reduces potency of calcium channel antagonists due to lower binding to the rat heart.

Authors:  Saeed Sattari; William F Dryden; Lise A Eliot; Fakhreddin Jamali
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 9.  Biophysical basis for airway hyperresponsiveness.

Authors:  Steven S An; Jeffrey J Fredberg
Journal:  Can J Physiol Pharmacol       Date:  2007-07       Impact factor: 2.273

Review 10.  Airway remodeling: lessons from animal models.

Authors:  David Ramos-Barbón; Mara S Ludwig; James G Martin
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.